Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):775–787. https://doi.org/10.1001/jama.2016.0289

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596. https://doi.org/10.1097/01.CCM.0000217961.75225.E9

Oda S, Aibiki M, Ikeda T, Imaizumi H, Endo S, Ochiai R, Kotani J, Shime N, Nishida O, Noguchi T, Matsuda N, Hirasawa H (2014) The Japanese guidelines for the management of sepsis. J Intensive Care 2(1):55. https://doi.org/10.1186/s40560-014-0055-2

Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, Takakura S, Tokimatsu I, Takahashi Y, Kasahara K, Okada K, Igarashi M, Kobayashi M, Hamada Y, Kimura M, Nishi Y, Tanigawara Y, Kimura T (2013) Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother 19(3):365–380. https://doi.org/10.1007/s10156-013-0599-4

Wong-Beringer A, Joo J, Tse E, Beringer P (2011) Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int J Antimicrob Agents 37(2):95–101. https://doi.org/10.1016/j.ijantimicag.2010.10.013

Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D (2013) Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med 39(7):1247–1252. https://doi.org/10.1007/s00134-013-2909-9

Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37(3):840–851. https://doi.org/10.1097/CCM.0b013e3181961bff

Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient—concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 77:3–11. https://doi.org/10.1016/j.addr.2014.07.006

Chuma M, Makishima M, Imai T, Tochikura N, Sakaue T, Kikuchi N, Kinoshita K, Kaburaki M, Yoshida Y (2016) Duration of systemic inflammatory response syndrome influences serum vancomycin concentration in patients with sepsis. Clin Ther 38(12):2598–2609. https://doi.org/10.1016/j.clinthera.2016.10.009

Nguyen BV, Bota DP, Melot C, Vincent JL (2003) Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 31(2):406–410. https://doi.org/10.1097/01.CCM.0000048623.00778.3F

Shapiro NI, Arnold R, Sherwin R, O’Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE (2011) The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care 15(5):R223. https://doi.org/10.1186/cc10463

Kopterides P, Theodorakopoulou M, Nikitas N, Ilias I, Vassiliadi DA, Orfanos SE, Tsangaris I, Maniatis NA, Tsantes AE, Travlou A, Dimitriadis G, Armaganidis A, Ungerstedt U, Dimopoulou I (2012) Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis. Intensive Care Med 38(11):1843–1850. https://doi.org/10.1007/s00134-012-2635-8

Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Komatsu T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K (2018) Relationship between initial vancomycin trough levels and early-onset vancomycin-associated nephrotoxicity in critically ill patients. Ther Drug Monit 40(1):109–114. https://doi.org/10.1097/FTD.0000000000000459

Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL (2009) Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 49(4):507–514. https://doi.org/10.1086/600884

Thavendiranathan P, Bagai A, Ebidia A, Detsky AS, Choudhry NK (2005) Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med 20(6):520–524. https://doi.org/10.1111/j.1525-1497.2005.0094.x

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818–829

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettila V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Muller RG, Moller MH, Steensen M, Tjader I, Kilsand K, Odeberg-Wernerman S, Sjobo B, Bundgaard H, Thyo MA, Lodahl D, Maerkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391. https://doi.org/10.1056/NEJMoa1406617

Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R (1998) Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit 20(2):139–148

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41

Hiraki Y, Onga T, Mizoguchi A, Tsuji Y (2010) Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis. J Clin Pharm Ther 35(5):527–532. https://doi.org/10.1111/j.1365-2710.2009.01126.x

Yamaoka K, Nakagawa T, Tanaka H, Yasuhara M, Okumura K, Hori R (1985) A nonlinear multiple regression program, MULTI2 (BAYES), based on Bayesian algorithm for microcomputers. J Pharmacobiodyn 8(4):246–256

Shimamoto Y, Fukuda T, Tominari S, Fukumoto K, Ueno K, Dong M, Tanaka K, Shirasaka T, Komori K (2013) Decreased vancomycin clearance in patients with congestive heart failure. Eur J Clin Pharmacol 69(3):449–457. https://doi.org/10.1007/s00228-012-1340-4

Ohnishi A, Yano Y, Shimamura K, Oguma T (2001) Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function. Biol Pharm Bull 24(12):1446–1450

Revilla N, Martin-Suarez A, Perez MP, Gonzalez FM, Fernandez de Gatta Mdel M (2010) Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol 70(2):201–212. https://doi.org/10.1111/j.1365-2125.2010.03679.x

Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138(11):923–936

Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9(4):503–512

Shander A (2004) Anemia in the critically ill. Crit Care Clin 20(2):159–178. https://doi.org/10.1016/j.ccc.2004.01.002

Raimundo M, Crichton S, Syed Y, Martin JR, Beale R, Treacher D, Ostermann M (2015) Low systemic oxygen delivery and BP and risk of progression of early AKI. Clin J Am Soc Nephrol 10(8):1340–1349. https://doi.org/10.2215/CJN.02780314

Armstrong BA, Betzold RD, May AK (2017) Sepsis and septic shock strategies. Surg Clin North Am 97(6):1339–1379. https://doi.org/10.1016/j.suc.2017.07.003

Kumar S, Gupta E, Kaushik S, Kumar Srivastava V, Mehta SK, Jyoti A (2018) Evaluation of oxidative stress and antioxidant status: correlation with the severity of sepsis. Scand J Immunol 87(4):e12653. https://doi.org/10.1111/sji.12653

Zafrani L, Ergin B, Kapucu A, Ince C (2016) Blood transfusion improves renal oxygenation and renal function in sepsis-induced acute kidney injury in rats. Crit Care 20(1):406. https://doi.org/10.1186/s13054-016-1581-1

Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301(6):H2181–H2190. https://doi.org/10.1152/ajpheart.00554.2011

Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356(9237):1213–1218. https://doi.org/10.1016/s0140-6736(00)02783-5

Harada H, Miyagawa S, Kawasaki S, Hayashi K, Kitamura H, Katsuyama Y, Atobe O, Tada A, Zenda H, Oguma T (1999) Study of the pharmacokinetics of vancomycin in patients with impaired liver function. J Infect Chemother 5(2):104–107. https://doi.org/10.1007/s101560050018

Bragadottir G, Redfors B, Ricksten SE (2013) Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury—true GFR versus urinary creatinine clearance and estimating equations. Crit Care 17(3):R108. https://doi.org/10.1186/cc12777

Carlier M, Dumoulin A, Janssen A, Picavet S, Vanthuyne S, Van Eynde R, Vanholder R, Delanghe J, De Schoenmakere G, De Waele JJ, Hoste EA (2015) Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med 41(3):427–435. https://doi.org/10.1007/s00134-014-3641-9